Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cimicoxib in combination with sertraline for major depression
NCT00510822Phase 2Completed
- Sponsor
- Affectis Pharmaceuticals AG
- Start
- Oct 2007
- Primary completion
- Feb 2010
- Countries
- 3
01
Overview
A Phase 2 trial of cimicoxib in major depressive disorder (MDD), sponsored by Affectis Pharmaceuticals AG. Started Oct 2007; status: completed.
02
Drugs
cimicoxib
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00510822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510822.